TMDX Deadline: TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Core Viewpoint - Rosen Law Firm is reminding investors who purchased TransMedics Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the TransMedics securities class action is from February 28, 2023, to January 10, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by April 15, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against TransMedics - The lawsuit alleges that TransMedics made materially false and misleading statements, including the use of kickbacks, fraudulent overbilling, and coercive tactics to generate revenue [5]. - It is claimed that TransMedics engaged in unsafe practices and concealed safety issues, leading to increased regulatory scrutiny [5]. - The misleading statements about the company's business and operations resulted in investor damages when the truth was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [4]. - The firm was ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4].